Results 151 to 160 of about 2,698,478 (214)
Efficacy and safety of Chinese patent medicine combined with 5-aminosalicylic acid for patients with ulcerative colitis: A network meta-analysis of randomized controlled trials. [PDF]
Zhang M +11 more
europepmc +1 more source
Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study. [PDF]
Shehab M +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Disposition of 5-Aminosalicylic Acid by 5-Aminosalicylic Acid-Delivering Compounds
Scandinavian Journal of Gastroenterology, 1988The disposition of 5-aminosalicylic acid (5-ASA) from 5-ASA-delivering drugs was studied in eight healthy volunteers. Time-related urinary excretion and faecal excretion of 5-ASA and acetyl-5-ASA were measured after a single oral dose of the azo compounds sulphasalazine and olsalazine, of the slow-release compounds Pentasa, Asacol, and Salofalk, and of
J H van Tongeren
exaly +4 more sources
Electroanalytical Overview: The Sensing of Mesalamine (5-Aminosalicylic Acid)
Mesalamine, known as 5-aminosalicylic acid, is a medication used primarily in the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.
Craig E Banks +2 more
exaly +1 more source
Glucose ester derivatives of aminosalicylic acids*
Journal of the American Pharmaceutical Association (Scientific ed.), 1955Glucose esters of 4‐ and 5‐aminosalicylic acid were obtainable by reaction of the benzyloxynitrobenzoic acid chlorides with diacetone glucose, followed by catalytic hydrogenation of the nitro groups. Conversion of the amines to hydrochlorides removed one or both of the acetone groups from the glucose.
W O, FOYE, E G, FELDMANN
openaire +2 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2019
Despite the emergence of new biological therapies that aim for mucosal healing as a new therapeutic target, the importance of 5-ASA formulations in the standard treatment for inflammatory bowel diseases, particularly ulcerative colitis, remains unchanged.
Tomoya, Iida +2 more
openaire +1 more source
Despite the emergence of new biological therapies that aim for mucosal healing as a new therapeutic target, the importance of 5-ASA formulations in the standard treatment for inflammatory bowel diseases, particularly ulcerative colitis, remains unchanged.
Tomoya, Iida +2 more
openaire +1 more source
Amino Acid Derivatives of Aminosalicylic Acids
Journal of Pharmaceutical Sciences, 1965W, Hoek, J, Ebels, J, Strating
openaire +2 more sources

